Why Did Jefferies Give Navitas Semiconductor Corp (NVTS) Stock Hold Rating?
Jefferies has recently reduced Navitas Semiconductor Corp (NVTS) stock to Hold rating, as announced on May 13, 2024, according to Finviz. Earlier, on January 16, 2024, Northland Capital had initiated the stock to Market Perform. Morgan Stanley also initiated research coverage with a price target of $9.20. Additionally, Rosenblatt initiated Buy rating on February 24, […]
What’s Fueling Vital Farms, Inc. (VITL) Stock’s -7.46% Loss Below Its 200-Day SMA?
TD Cowen has recently raised Vital Farms, Inc. (VITL) stock to Buy rating, as announced on August 9, 2024, according to Finviz. Earlier, on May 10, 2024, Stifel had reduced the stock from a Buy to Hold, setting a price target of $40 for VITL stock. William Blair also initiated Outperform rating. Additionally, DA Davidson […]
Vertex Inc (VERX) Posted 4.73% Profit Margin Last Year—Can It Hold Up?
Jefferies has recently raised Vertex Inc (VERX) stock to Buy rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 23, 2024, Robert W. Baird had initiated the stock to Outperform, setting a price target of $43. BofA Securities also raised Neutral rating with a price target of $40. Additionally, Morgan Stanley […]
RingCentral Inc (RNG) Reported a -1.57% Operating Margin Last Year—What’s the Real Story?
Rosenblatt has recently raised RingCentral Inc (RNG) stock to Buy rating, as announced on August 2, 2024, according to Finviz. Earlier, on December 20, 2023, Wells Fargo had reduced the stock from a Overweight to Equal Weight, setting a price target of $36. Jefferies also reduced Hold rating with a price target of $35. Additionally, […]
What’s Driving CytomX Therapeutics Inc (CTMX) Stock’s -9.57% Plunge Over the Past Month?
Piper Sandler has recently raised CytomX Therapeutics Inc (CTMX) stock to Overweight rating, as announced on May 28, 2024, according to Finviz. Earlier, on May 9, 2024, Wedbush had raised the stock from a Neutral to Outperform, setting a price target of $8. Jefferies also raised Buy rating with a price target of $8. Additionally, […]
Why Did Tripadvisor Inc Common Stock (TRIP) Stock Tumble -4.45% to $14.8?
Cantor Fitzgerald has recently initiated Tripadvisor Inc Common Stock (TRIP) stock to Underweight rating, as announced on September 5, 2024, according to Finviz. Earlier, on August 7, 2024, B. Riley Securities had reduced the stock from a Buy to Neutral, setting a price target of $19 for TRIP stock. DA Davidson also reduced Neutral rating […]
Analysts Predict a $1.50 Target for Coherus Biosciences Inc (CHRS) Stock—What Could Drive It There?
UBS has recently reduced Coherus Biosciences Inc (CHRS) stock to Neutral rating, as announced on August 16, 2024, according to Finviz. Earlier, on November 17, 2023, Robert W. Baird had initiated the stock to Outperform, setting a price target of $11. Maxim Group also reduced Hold rating. Additionally, Citigroup initiated Buy rating on July 24, […]
What’s Behind the -4.30% Drop in Altimmune Inc (ALT) Stock? Find Out Now!
Guggenheim has recently reduced Altimmune Inc (ALT) stock to Neutral rating, as announced on April 29, 2024, according to Finviz. Earlier, on January 24, 2024, Goldman had initiated the stock to Neutral, setting a price target of $13. Goldman also reduced Neutral rating with a price target of $6. Additionally, Goldman initiated Buy rating on […]
Redburn Atlantic Just Initiated Lantheus Holdings Inc (LNTH) Stock—What Does This Mean for Investors?
Redburn Atlantic has recently initiated Lantheus Holdings Inc (LNTH) stock to Buy rating, as announced on September 3, 2024, according to Finviz. Earlier, on July 10, 2024, JMP Securities had reiterated the stock to Mkt Outperform, setting a price target of $130 for LNTH stock. William Blair also reduced Mkt Perform rating. Additionally, TD Cowen […]
How Does Wendy’s Co (WEN) Stack Up Against Its Industry Peers?
Goldman has recently initiated Wendy’s Co (WEN) stock to Sell rating, as announced on June 13, 2024, according to Finviz. Earlier, on April 12, 2024, Stephens had resumed the stock rating, setting a price target of $20. Bernstein also reduced Mkt Perform rating with a price target of $20. Additionally, JP Morgan reduced Neutral rating […]
